VRTX - Vertex Pharmaceuticals Inc / Ma - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - VRTX (875320)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-06-12
VRTXBozic CarmenEVP, CMOS - Sale$478.00-2,28032,379-7%-$1,089,840
2024-06-12
VRTXAtkinson Edward Morrow IIIEVP, Chief Technical Ops. OffiS - Sale$478.00-7,28815,972-31%-$3,483,664
2024-06-03
VRTXWagner Charles F JrEVP, CFOS - Sale$460.00-3,25047,137-6%-$1,495,000
2024-06-03
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$460.00-2,17549,098-4%-$1,000,500
M
2024-05-30
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$441.99-4,60051,273-8%-$2,033,159
2024-05-29
VRTXBozic CarmenEVP, CMOS - Sale$445.56-2,28034,659-6%-$1,015,877
2024-05-28
VRTXWagner Charles F JrEVP, CFOS - Sale$454.79-3,25050,387-6%-$1,478,068
D
2024-05-24
VRTXKewalramani ReshmaCEO, PresS - Sale+OE$457.00-1,565121,374-1%-$715,205
D
2024-05-22
VRTXSachs Bruce IDirS - Sale+OE$448.00-7,07340,000-15%-$3,168,704
2024-05-20
VRTXKewalramani ReshmaCEO, PresS - Sale$447.00-15,202121,374-11%-$6,795,294
2024-05-15
VRTXSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$430.93-3262,7720%-$13,790
2024-05-15
VRTXArbuckle Stuart AEVP, COOS - Sale$430.93-6949,8310%-$29,734
2024-05-15
VRTXAltshuler DavidEVP, Chief Scientific OfficerS - Sale$430.93-5425,8130%-$23,270
2024-05-02
VRTXBhatia Sangeeta N.DirS - Sale$402.95-4674,435-10%-$188,178
2024-04-02
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$419.00-2407,500-3%-$100,560
2024-02-26
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$425.70-35455,804-1%-$150,698
2024-02-26
VRTXSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$425.70-3,00462,772-5%-$1,278,803
2024-02-26
VRTXAtkinson Edward Morrow IIIEVP, Chief Technical Ops. OffiS - Sale$425.70-88315,972-5%-$375,893
2024-02-26
VRTXArbuckle Stuart AEVP, COOS - Sale$425.70-5,03449,831-9%-$2,142,974
2024-02-26
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$425.70-8837,965-10%-$375,893
2024-02-26
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$425.70-4,23925,813-14%-$1,804,542
2024-02-21
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$421.77-36059,467-1%-$151,837
2024-02-21
VRTXAtkinson Edward Morrow IIIEVP, Chief Technical Ops. OffiS - Sale$421.77-1,20118,509-6%-$506,546
2024-02-21
VRTXArbuckle Stuart AEVP, COOS - Sale$421.77-3,60359,579-6%-$1,519,637
2024-02-21
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$421.77-3,00234,022-8%-$1,266,154
2024-02-20
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$420.79-48059,827-1%-$201,979
2024-02-20
VRTXSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$420.79-4,25471,436-6%-$1,790,041
2024-02-20
VRTXAtkinson Edward Morrow IIIEVP, Chief Technical Ops. OffiS - Sale$420.79-80119,710-4%-$337,053
2024-02-20
VRTXArbuckle Stuart AEVP, COOS - Sale$420.79-4,80463,182-7%-$2,021,475
2024-02-20
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$420.79-4,00237,024-10%-$1,684,002
M
2024-02-14
VRTXLeiden Jeffrey MExec COBS - Sale$419.10-9,01118,336-33%-$3,776,528
M
2024-02-12
VRTXLeiden Jeffrey MExec COBS - Sale$419.42-3,39327,347-11%-$1,423,104
2024-02-12
VRTXSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$420.24-3,22281,811-4%-$1,354,013
2024-02-12
VRTXBiller JonathanEVP, GCS - Sale$418.77-1,73818,280-9%-$727,822
2024-02-12
VRTXAtkinson Edward Morrow IIIEVP, Chief Technical Ops. OffiS - Sale$420.24-91323,137-4%-$383,679
2024-02-12
VRTXArbuckle Stuart AEVP, COOS - Sale$420.24-4,29575,858-5%-$1,804,931
2024-02-12
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$420.24-1,3749,676-12%-$577,410
2024-02-12
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$420.24-3,14547,588-6%-$1,321,655
2024-01-08
VRTXLeiden Jeffrey MExec COBS - Sale$419.07-6,6482,863-70%-$2,785,977
2024-01-02
VRTXWagner Charles F JrEVP, CFOS - Sale$405.00-3,00043,693-6%-$1,215,000
D
2023-12-15
VRTXKewalramani ReshmaCEO, PresS - Sale+OE$407.00-17,135108,711-14%-$6,973,945
2023-12-13
VRTXLeiden Jeffrey MExec COBS - Sale$399.42-13,3549,511-58%-$5,333,799
2023-12-13
VRTXKewalramani ReshmaCEO, PresS - Sale$397.00-5,098108,711-4%-$2,023,906
D
2023-12-13
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$399.00-8,60356,696-13%-$3,432,597
2023-11-20
VRTXWagner Charles F JrEVP, CFOS - Sale$349.88-3,00046,693-6%-$1,049,640
2023-11-15
VRTXSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$369.92-3566,2610%-$12,947
2023-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$369.92-1932,0380%-$7,028
2023-11-14
VRTXBozic CarmenEVP, CMOS - Sale$380.82-5,65029,302-16%-$2,151,633
2023-11-13
VRTXKewalramani ReshmaCEO, PresS - Sale$377.00-5,097113,809-4%-$1,921,569
D
2023-11-06
VRTXSachs Bruce IDirS - Sale+OE$385.00-11,25040,000-22%-$4,331,250
2023-10-31
VRTXBozic CarmenEVP, CMOS - Sale$355.92-5,65134,952-14%-$2,011,304
2023-10-17
VRTXBozic CarmenEVP, CMOS - Sale$373.25-5,65140,603-12%-$2,109,236
2023-10-17
VRTXBhatia Sangeeta N.DirS - Sale$375.00-2433,901-6%-$91,125
2023-10-16
VRTXLeiden Jeffrey MExec COBS - Sale$374.00-12,96222,865-36%-$4,847,788
2023-10-06
VRTXBhatia Sangeeta N.DirS - Sale$360.00-2424,144-6%-$87,120
2023-10-03
VRTXBozic CarmenEVP, CMOS - Sale$345.28-5,65146,254-11%-$1,951,177
2023-10-02
VRTXBiller JonathanEVP, GCS - Sale$346.76-61010,569-5%-$211,524
2023-09-19
VRTXBozic CarmenEVP, CMOS - Sale$351.00-5,65151,905-10%-$1,983,501
2023-09-05
VRTXBozic CarmenEVP, CMOS - Sale$352.66-5,65157,556-9%-$1,992,882
2023-08-23
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$355.00-2,50048,637-5%-$887,500
D
2023-08-10
VRTXKearney Terrence CDirS - Sale+OE$350.00-10,0006,536-60%-$3,500,000
2023-08-10
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$345.79-5,75051,137-10%-$1,988,293
2023-08-10
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$350.00-10,03166,261-13%-$3,510,850
2023-08-09
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$345.51-6332,0380%-$21,767
2023-08-09
VRTXBhatia Sangeeta N.DirS - Sale$345.51-2424,386-5%-$83,613
D
2023-07-17
VRTXSachs Bruce IDirS - Sale+OE$356.75-11,25040,000-22%-$4,013,459
2023-07-17
VRTXKewalramani ReshmaCEO, PresS - Sale$355.00-7,828118,906-6%-$2,778,940
D
2023-06-15
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$349.00-8,60356,696-13%-$3,002,447
2023-05-30
VRTXArbuckle Stuart AEVP, COOS - Sale$329.82-8256,6960%-$27,045
2023-05-30
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$329.82-2896,838-4%-$95,318
M
2023-05-05
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$350.00-3,27232,038-9%-$1,145,213
M
2023-05-05
VRTXLeiden Jeffrey MExec COBS - Sale$349.25-2,00435,827-5%-$699,887
M
2023-05-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$350.71-4,40335,310-11%-$1,544,187
M
2023-05-02
VRTXLeiden Jeffrey MExec COBS - Sale$349.98-10,95837,831-22%-$3,835,062
2023-05-02
VRTXBhatia Sangeeta N.DirS - Sale$348.28-5804,628-11%-$202,004
2023-04-27
VRTXKewalramani ReshmaCEO, PresS - Sale$339.08-3,317126,652-3%-$1,124,726
2023-04-12
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$326.70-7,56739,713-16%-$2,472,164
D
2023-04-12
VRTXSachs Bruce IDirS - Sale+OE$326.73-21,30040,000-35%-$6,959,422
2023-04-04
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$315.81-52247,280-1%-$164,854
2023-03-24
VRTXWagner Charles F JrEVP, CFOS - Sale$305.38-1,76849,611-3%-$539,912
2023-03-17
VRTXWagner Charles F JrEVP, CFOS - Sale$296.39-2,00051,379-4%-$592,786
2023-03-16
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.59-2,74649,268-5%-$825,423
M
2023-03-10
VRTXWagner Charles F JrEVP, CFOS - Sale$291.98-4,75453,379-8%-$1,388,054
2023-02-27
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$287.48-35456,805-1%-$101,768
2023-02-27
VRTXArbuckle Stuart AEVP, COOS - Sale$287.47-5,03456,696-8%-$1,447,143
2023-02-27
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$287.55-1,2077,303-14%-$347,072
2023-02-27
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$287.51-4,23832,038-12%-$1,218,449
2023-02-22
VRTXArbuckle Stuart AEVP, COOS - Sale$294.33-2,40166,444-3%-$706,679
2023-02-21
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$293.75-48060,467-1%-$141,002
2023-02-21
VRTXArbuckle Stuart AEVP, COOS - Sale$293.75-2,40268,845-3%-$705,596
2023-02-21
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$293.77-4,00240,246-9%-$1,175,676
2023-02-14
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.52-32065,4450%-$95,527
2023-02-14
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.40-2,18159,734-4%-$655,161
2023-02-14
VRTXArbuckle Stuart AEVP, COOS - Sale$298.68-6,39875,745-8%-$1,910,962
2023-02-14
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$298.70-6,39847,998-12%-$1,911,108
2023-02-13
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.99-27565,7650%-$82,223
2023-02-13
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.39-11361,9150%-$33,944
2023-02-13
VRTXArbuckle Stuart AEVP, COOS - Sale$298.92-4,88782,143-6%-$1,460,816
2023-02-13
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$298.90-4,79854,396-8%-$1,434,126
D
2023-02-06
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$306.00-1,30468,645-2%-$399,022

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top